Advertisement
The Leading Source for Pharmaceutical & Biopharmaceutical Manufacturing News
Subscribe to Pharmaceutical Processing

The Lead

AbbVie Hikes Forecast, Tops Wall Street Expectations

October 31, 2014 | by TOM MURPHY, AP Business Writer | News | Comments

AbbVie surprised Wall Street today with a third-quarter performance that turned out much better than expected and a new 2014 forecast that also extends well beyond what analysts predict.           

TOPICS:
View Sample

FREE Daily Email Newsletter

Ensuring Dedusting Efficiency by Design

October 31, 2014 3:03 pm | by Nic Michel, General Manager, North America, Pharma Technology Inc. | Articles | Comments

Dust has always been an unwanted byproduct of tablet manufacturing. In a perfect world, all powder would flawlessly flow into the hopper, and 100% of the product would emerge as finished tablets. In practice, though, most tablet presses are so inundated with dust after an eight-hour run that they form miniature snow piles on both sides of the feeder, and build-ups of material occur around the takeoff bar and recirculation channel.

Lawsuit: Surgical Gowns Let Diseases Pass Through

October 31, 2014 2:39 pm | by ROBERT JABLON, Associated Press | News | Comments

A $500M lawsuit against Kimberly-Clark alleges the company falsely claimed its surgical gowns protected against Ebola and other infectious diseases. The suit alleges that the company knew for at least a year that its Microcool Breathable High Performance Surgical Gown had failed industry tests of impermeability to blood and microbes.

TOPICS:

Instruments for Process Recording and Control

October 31, 2014 2:34 pm | Product Releases | Comments

Brochure details the company's comprehensive range of recording and controlling instrumentation for a broad range of industries. Under the brand names ScreenMaster, ControlMaster and Commander, the products include process controllers, digital indicators, chart and strip recorders and paperless videographic recorders.

Advertisement

The Biosimilars Market

October 31, 2014 11:19 am | by Sarfaraz K. Niazi, Ph.D., Founding Chairman and CEO, Therapeutic Proteins International | Articles | Comments

Biosimilars have increasingly become an important and somewhat controversial topic in the healthcare space. Depending on who one speaks to, the opinion on biosimilars changes. However, there are certain truths that all stakeholders should keep in mind.

TOPICS:

High Potency, High Reward

October 31, 2014 10:43 am | by Nikita Ernst, Associate Editor | Articles | Comments

SAFC, a global supplier of a a wide range of services to the biopharm and pharmaceutical industry, has recently expanded their Madison, Wisconsin facilities to neighboring Verona to rev up their high-potency API manufacturing capabilities.

TOPICS:

Clear Flexible Film for High-Barrier Pharmaceutical Applications

October 31, 2014 10:12 am | Product Releases | Comments

Exponent™ 2 features a combination of ClearFoil® and a coextruded non-crystalline polyester sealant. The material targets pharmaceutical and other chemically-sensitive applications which require exceptional barrier and clarity.

Is Drinking Soda as Harmful as Smoking?

October 31, 2014 8:16 am | Videos | Comments

CNN's Anderson Cooper investigates a new study comparing the effects of drinking soda to smoking.                          

TOPICS:

New Advice for Dialysis Patients; Diet and Kidney Problems

October 31, 2014 8:10 am | Videos | Comments

Dialysis patients need to choose their heart medicine carefully, as Canadian researchers say that some beta blockers are easily removed from the blood during treatment. Also, people who eat a Mediterranean diet may decrease their risk of developing kidney problems.

TOPICS:
Advertisement

Medicare Bought Meds for Dead People

October 31, 2014 7:59 am | by RICARDO ALONSO-ZALDIVAR, Associated Press | News | Comments

Call it drugs for the departed: Medicare's prescription program kept paying for costly medications even after patients were dead. The problem was traced back to a head-scratching bureaucratic rule that's now getting a second look.    

TOPICS:

Impax Announces R&D Reorganization, Layoffs

October 30, 2014 4:25 pm | News | Comments

Impax Laboratories has announced a reorganization of its research and development (R&D) organizations and a prioritization of the project portfolios within the generic and brand businesses          

TOPICS:

Sanitary Belt Conveyor

October 30, 2014 3:32 pm | Product Releases | Comments

Sanitary Belt Conveyor is designed for bulk tablets, capsules, softgels, and powders as well as ingredients on regulated and OTC pharmaceutical and nutritional supplement manufacturing and packaging lines.

Fearing Ebola? Doctors Say Get a Flu Shot

October 30, 2014 3:10 pm | by LINDSEY TANNER, AP Medical Writer | News | Comments

Fever? Headache? Muscle aches? Forget about Ebola — chances are astronomically higher that you have the flu or some other common bug. That message still hasn't reached many Americans, judging from stories ER doctors and nurses swapped this week at a Chicago medical conference.

TOPICS:

FTC Sues Gerber Over Claims on Infant Formula

October 30, 2014 2:02 pm | by ANNE FLAHERTY, Associated Press | News | Comments

Federal regulators announced Thursday they were suing Gerber, the well-known baby food maker, for claiming that its Good Start Gentle formula can prevent or reduce allergies in children.           

TOPICS:

Bristol-Myers Squibb and Lonza Expand Manufacturing Agreement

October 30, 2014 1:34 pm | News | Comments

Bristol-Myers Squibb and Lonza have announced a multi-year expansion of their existing biologics manufacturing agreement. The contract expansion will include the production of commercial quantities of a second Bristol-Myers Squibb biologic medicine at Lonza’s mammalian manufacturing facility in Portsmouth, NH.

TOPICS:

Chinese Pharma Firm to Establish Operations in Virginia

October 30, 2014 12:56 pm | News | Comments

Virginia's Gov. Terry McAuliffe said Thursday that UniTao Pharmaceuticals LLC has purchased the Boehringer Ingelheim plant that's slated to close by the end of the year.              

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading